Paper86043
Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
van Breukelen FJ and 2 others. Lancet, 1979. Cited by 179 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). Papers, record 86043. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/86043
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Resorption | Major topic |
| Diphosphonates | Major topic |
| Osteolysis | Major topic |
| Breast Neoplasms | |
| Calcium | |
| Creatinine | |
| Female | |
| Humans | |
| Hydroxyproline | |
| Hypercalcemia | |
| Multiple Myeloma | |
| Propanolamines |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 179 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24048722 | Atypical femoral fractures: a review of the literature. | Curr Osteoporos Rep | 2013 | https://conductscience.org/library/papers/24048722 | PubMed |
| 21847749 | Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies. | Skeletal Radiol | 2011 | https://conductscience.org/library/papers/21847749 | PubMed |
| 10319239 | Bisphosphonate treatment of lytic bone metastases. | Drugs Aging | 1999 | https://conductscience.org/library/papers/10319239 | PubMed |
| 8287315 | Decrease of serum calcium concentration and lost influence of calcium on parathyroid hormone release in a patient with primary hyperparathyroidism after treatment with diphosphonates. | Calcif Tissue Int | 1993 | https://conductscience.org/library/papers/8287315 | PubMed |
| 7130396 | Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7130396 | PubMed |
| 6871766 | Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). | Calcif Tissue Int | 1983 | https://conductscience.org/library/papers/6871766 | PubMed |
| 6839194 | Structure-activity relationships of various bisphosphonates. | Calcif Tissue Int | 1983 | https://conductscience.org/library/papers/6839194 | PubMed |
| 6814719 | Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium. | Calcif Tissue Int | 1982 | https://conductscience.org/library/papers/6814719 | PubMed |
| 6773632 | Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats. | Calcif Tissue Int | 1980 | https://conductscience.org/library/papers/6773632 | PubMed |
| 6468624 | The bisphosphonates HEBP and AHPrBP but not AHBP inhibit mineral mobilization and lysosomal enzyme release from mouse calvarial bones in tissue culture. | Experientia | 1984 | https://conductscience.org/library/papers/6468624 | PubMed |
| 6459838 | Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate. | Calcif Tissue Int | 1981 | https://conductscience.org/library/papers/6459838 | PubMed |
| 6459147 | Effect of diphosphonates on the synthesis of prostaglandins in cultured calvaria cells. | Calcif Tissue Int | 1981 | https://conductscience.org/library/papers/6459147 | PubMed |
| 6456927 | The effect of diphosphonates on periosteal and bone cells in culture. | Experientia | 1981 | https://conductscience.org/library/papers/6456927 | PubMed |
| 6444955 | Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6444955 | PubMed |
| 6423103 | Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6423103 | PubMed |
| 6423093 | Treatment of hypercalcaemia associated with malignancy. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6423093 | PubMed |
| 6402083 | Disequilibrium hypercalcaemia. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6402083 | PubMed |
| 6355639 | [Hypocalcemia in malignant diseases]. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6355639 | PubMed |
| 6311375 | The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor. | Calcif Tissue Int | 1983 | https://conductscience.org/library/papers/6311375 | PubMed |
| 6227496 | The effect of bisphosphonates on glycolysis in cultured calvaria cells and their homogenate. | Experientia | 1983 | https://conductscience.org/library/papers/6227496 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/86043
GET https://conductscience.org/api/papers/v1/86043/cited_by?page=2